EUDA Health Holdings Ltd (EUDA) EBITDA (2022 - 2023)
EUDA Health Holdings (EUDA) posted quarterly EBITDA of -$738974.0 for Q2 2023, up 57.24% year-over-year from -$469972.2 in Q2 2022, and up 62.62% quarter-over-quarter from -$2.0 million in Q1 2023.
EUDA Health Holdings Ltd (EUDA) EBITDA (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDA) has reported EBITDA for 2 consecutive years, with -$738974.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, EBITDA rose 57.24% year-over-year to -$738974.0; the TTM figure through Jun 2023 stood at -$14.5 million (changed N/A YoY), while the FY2025 annual figure was -$2.5 million, up 85.71% from the prior year.
- EBITDA advanced to -$738974.0 in Q2 2023 per EUDA's latest filing, from -$2.0 million in the prior quarter.
- Across five years, EBITDA topped out at $75312.0 in Q1 2022 and bottomed at -$11.5 million in Q4 2022.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -738,974.00 |
| Mar 31, 2023 | -1.98 Mn |
| Dec 31, 2022 | -11.47 Mn |
| Oct 31, 2022 | -298,331.00 |
| Jun 30, 2022 | -1.73 Mn |
| Mar 31, 2022 | 75,312.00 |